Hemophilia A complicated by inhibitors remains one of the most difficult challenges in bleeding disorder management, often rendering standard factor replacement ineffective and increasing the risk of life-threatening bleeds. With rapid advances in bypassing agents, novel non-factor therapies, and evolving treatment strategies, the landscape of care is undergoing a significant transformation.
In this session, Dr. Rajesh Kashyap will explore the current approaches to managing Hemophilia A with inhibitors, highlighting recent innovations, practical considerations in clinical practice, and the promise of emerging therapies. Clinicians will gain a deeper understanding of how to navigate these complex cases and optimize outcomes in the era of changing hemophilia care.

Management of Hemophilia A with inhibitor in current changing landscape

In this session, the focus is on creating awareness and covering unmet medical needs about Prophylaxis and Inhibitor management among the hematologist community, which plays an eminent role in the care of Hemophilia A patients. This insightful session would empower doctors scientifically with the latest clinical acumen and would help in better decision making, thereby building the reputation of Hemophilia doctors.

Hemophilia A Management : Present Challenges and Future Opportunities

Professor & Head Of Department of Clinical hematology & Stem Cell Research Center, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow

Dr. Rajesh Kashyap

2

435

8k

4.4

Sessions Taken

182

4.5

300

4.3